Targeting LTBP2 Reveals a Novel Anti-Cardiac Remodeling Mechanism of Finerenone Against Doxorubicin-Induced CardiotoxicityHeng Zhang, Wei Deng, Saiyang Xie et al.|Biomolecules|2025Cited by 0